Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)

Pilar RamosDivision of Integrated Cancer Genomics; Translational Genomics Research Institute (TGen); Phoenix, AZUSA;School of Life Sciences; Arizona State University; Tempe, AZUSA

Anthony N KarnezisDepartment of Pathology and Laboratory Medicine; The University of British Columbia; Vancouver, BCCanada;Centre for Translational and Applied Genomics; British Columbia Cancer Agency; Vancouver, BCCanada

William P D HendricksDivision of Integrated Cancer Genomics; Translational Genomics Research Institute (TGen); Phoenix, AZUSA

Yemin WangDepartment of Pathology and Laboratory Medicine; The University of British Columbia; Vancouver, BCCanada;Centre for Translational and Applied Genomics; British Columbia Cancer Agency; Vancouver, BCCanada

Waibhav TembeCollaborative Bioinformatics Center; Translational Genomics Research Institute (TGen); Phoenix, AZUSA

Victoria L ZismannDivision of Integrated Cancer Genomics; Translational Genomics Research Institute (TGen); Phoenix, AZUSA

Christophe LegendreCollaborative Bioinformatics Center; Translational Genomics Research Institute (TGen); Phoenix, AZUSA

Winnie S LiangDivision of Integrated Cancer Genomics; Translational Genomics Research Institute (TGen); Phoenix, AZUSA

Megan L RussellDivision of Integrated Cancer Genomics; Translational Genomics Research Institute (TGen); Phoenix, AZUSA

David W CraigDivision of Integrated Cancer Genomics; Translational Genomics Research Institute (TGen); Phoenix, AZUSA

John H FarleyDepartment of Obstetrics and Gynecology; Creighton University School of Medicine; St. Joseph's Hospital and Medical Center; Phoenix, AZUSA

Bradley J MonkDepartment of Obstetrics and Gynecology; Creighton University School of Medicine; St. Joseph's Hospital and Medical Center; Phoenix, AZUSA

Stephen P AnthonyEvergreen Hematology and Oncology; Spokane, WAUSA

Aleksandar SekulicDivision of Integrated Cancer Genomics; Translational Genomics Research Institute (TGen); Phoenix, AZUSA;Department of Dermatology; Mayo Clinic; Scottsdale, AZUSA

Heather E CunliffeDepartment of Pathology; Dunedin School of Medicine; University of Otago; Dunedin, New Zealand

David G HuntsmanDepartment of Pathology and Laboratory Medicine; The University of British Columbia; Vancouver, BCCanada;Centre for Translational and Applied Genomics; British Columbia Cancer Agency; Vancouver, BCCanada

Jeffrey M TrentDivision of Integrated Cancer Genomics; Translational Genomics Research Institute (TGen); Phoenix, AZUSACorrespondence[email protected]

show all

Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)

967148_Supplementary_Materials.zip

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)

967148_Supplementary_Materials.zip

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date